Effectiveness and safety of intracranial events associated with the use of direct oral anticoagulants for atrial fibrillation: A systematic review and meta‐analysis of 92 …

P Archontakis‐Barakakis, W Li… - British Journal of …, 2022 - Wiley Online Library
Aims Observational studies have investigated the effectiveness and safety of direct oral
anticoagulants (DOACs) and vitamin K antagonists (VKAs) used in nonvalvular atrial …

[HTML][HTML] Major Hemorrhage Risk Associated with Direct Oral Anticoagulants in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis

P Archontakis-Barakakis, DG Kokkinidis… - Reviews in …, 2022 - imrpress.com
Background: Real-world, observational studies have investigated the safety profile of Direct
Oral Anticoagulants (DOACs) on Major Hemorrhage (MH) used for stroke prevention in Non …

[HTML][HTML] Time trends in antithrombotic therapy prescription patterns: Real-world monocentric study in hospitalized patients with atrial fibrillation

MG Abrignani, A Lombardo, A Braschi… - World Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Since 2010, the European Society of Cardiology has extended prescription
criteria for oral antithrombotic therapy (OAT) in atrial fibrillation (AF). Direct oral …

[HTML][HTML] Comparison of clinical effects and costs among dabigatran etexilate, rivaroxaban and warfarin in elderly patients with atrial fibrillation

J Di, Y Wei, G Zhang, Y Yue, S Sun - American Journal of …, 2023 - ncbi.nlm.nih.gov
Objective: To analyze the clinical effects and economic costs between Warfarin and novel
oral anticoagulants in elderly patients with atrial fibrillation (AF). Methods: This is a …

Safety of Direct Oral Anticoagulants for Gastrointestinal Hemorrhage in Patients With Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-analysis of Real …

PA Barakakis, DG Kokkinidis, W Li… - Journal of Clinical …, 2023 - journals.lww.com
Results: A total of 46 studies were included. Apixaban was associated with a reduced risk of
GIH compared with Dabigatran (HR: 0.67, 95% CI, 0.56 to 0.81, I 2: 53.28%), Rivaroxaban …

[PDF][PDF] REAL-WORLD EFFECTIVENESS AND SAFETY OF DIRECT ORAL ANTICOAGULANTS AND WARFARIN IN PATIENTS WITH NONVALVULAR ATRIAL …

S Suwatcharangkoon - rama.mahidol.ac.th
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia with increasing
prevalence over the past decades. 1, 2 Patients with AF increased risk for hospitalization …